Embrey M, Adams E E, Cunningham B, Peters W, Young V L, Carlo G L
Breast Implant Public Health Project, LLC, Washington, DC 20036, USA.
Aesthetic Plast Surg. 1999 May-Jun;23(3):197-206. doi: 10.1007/s002669900268.
The etiology of capsular contracture is unclear and probably multifactorial. This review covers the literature on several proposed contracture factors, including filler material, implant placement, surface texture, and bacterial infection. The pilot study's goal was to test the feasibility of a data collection form, which could be used in a scaled-up study analyzing multiple surgeon's records. The goal of the expanded version of this study will be to determine the efficacy of available interventions for capsular contracture, including surveillance. The Breast Implant Public Health Project, LLC (BIPHP), piloted a retrospective review of outcomes in women who had interventions to relieve capsular contracture or had chosen a wait-and-watch approach. An evaluation of the efficacy of various treatments can help women decide if they want to pursue treatment at all and, if so, which treatment might offer them the best solution. BIPHP researchers (E.E.A., M.E.) developed a data collection form after reviewing records of three surgeons (B.C., W.P., V.L.Y.). During the data collection using the same records, we tested a randomization process to identify women with capsular contracture who underwent various interventions, including a wait-and-watch strategy, and those who had no mention of any intervention or waiting approach. Data were gathered on a total of 90 breasts with capsular contracture (scored Baker I-IV or qualitatively), of which 45 underwent a total of 102 interventions for capsular contracture. Interventions were classified as "closed capsulotomy," "surgical," or "watchful waiting." Closed capsulotomy was performed most often (47%), followed by surgery (29%) and watchful waiting (21%). Presurgical Baker scores averaged higher in breasts that underwent surgery (3.1) than for watchful waiting (2.5) or closed capsulotomy (2.3). Though closed capsulotomies had 100% of outcomes scoring "improved" or "same," 58% of the breasts underwent the procedure more than once, suggesting that the favorable outcome was short-lived. The wait-and-watch approach resulted in scores of either "same" or "worse"; surgery (open capsulotomy, repositioning, or capsulectomy) resulted in 79% improved, 16% same, and 5% worse outcomes in breasts with outcomes listed. In all intervention procedure categories, outcomes were frequently unavailable; they were noted only 60% of the time (52/87). The missing 40% may have resulted from the doctor's failure to note it in the chart, satisfied patients not returning for additional treatment, or dissatisfied patients seeking treatment elsewhere. Generally, the data collection forms and procedures were workable; however, we uncovered issues to address in the scale-up of this pilot study: (1) the outcome report rate was 60%; (2) though Baker scores are commonly used to evaluate the degree of capsular contracture, it seems that grade I may have different meanings for different surgeons, which would need to be clarified; (3) participating surgeons will need to divulge standard-of-care items that they may not have included in medical records, but routinely performed (e.g., patient massage, use of prophylactic antibiotics); and (4) records were initially separated by "implant," then researchers realized that a more useful collection would be by "breast." The latter approach captures the history of the breast in one record, which may be more important to contracture than the differences in implants. With the modifications discussed, the study can be scaled up to encompass as many records as necessary to achieve robust statistical power. These data will add to the existing literature regarding factors associated with capsular contracture and identify factors that affect the successful outcome of capsular contracture interventions.
包膜挛缩的病因尚不清楚,可能是多因素的。本综述涵盖了关于几种提出的挛缩因素的文献,包括填充材料、植入物放置、表面纹理和细菌感染。该初步研究的目标是测试一种数据收集表的可行性,该表可用于一项扩大规模的研究,分析多位外科医生的记录。本研究扩展版本的目标将是确定现有包膜挛缩干预措施(包括监测)的疗效。乳房植入物公共卫生项目有限责任公司(BIPHP)对接受干预以缓解包膜挛缩或选择观察等待方法的女性的结局进行了回顾性研究。评估各种治疗方法的疗效可以帮助女性决定是否要寻求治疗,如果是,哪种治疗方法可能为她们提供最佳解决方案。BIPHP的研究人员(E.E.A.,M.E.)在审查了三位外科医生(B.C.,W.P.,V.L.Y.)的记录后制定了一份数据收集表。在使用相同记录进行数据收集期间,我们测试了一种随机化过程,以识别接受各种干预措施(包括观察等待策略)的包膜挛缩女性,以及那些未提及任何干预措施或等待方法的女性。总共收集了90例有包膜挛缩的乳房的数据(根据贝克I-IV级评分或定性),其中45例乳房总共接受了102次包膜挛缩干预措施。干预措施分为“闭合性包膜切开术”、“手术”或“观察等待”。闭合性包膜切开术最常进行(47%),其次是手术(29%)和观察等待(21%)。接受手术的乳房术前贝克评分平均(3.1)高于观察等待(2.5)或闭合性包膜切开术(2.3)。尽管闭合性包膜切开术的所有结局评分均为“改善”或“相同”,但58%的乳房不止接受了一次该手术,这表明良好的结局是短暂的。观察等待方法导致评分“相同”或“更差”;手术(开放性包膜切开术、重新定位或包膜切除术)导致列出结局的乳房中79%改善、16%相同、5%更差。在所有干预程序类别中,结局经常无法获得;仅60%的时间(52/87)有记录。缺失的40%可能是由于医生未在病历中记录、满意的患者未返回接受进一步治疗或不满意的患者在其他地方寻求治疗。总体而言,数据收集表和程序是可行的;然而,我们发现了在扩大该初步研究规模时需要解决的问题:(1)结局报告率为60%;(2)尽管贝克评分通常用于评估包膜挛缩的程度,但对于不同的外科医生,I级似乎可能有不同的含义,这需要澄清;(3)参与的外科医生需要透露他们可能未记录在病历中但常规进行的标准护理项目(例如,患者按摩、预防性抗生素的使用);(4)记录最初按“植入物”分开,然后研究人员意识到按“乳房”收集会更有用。后一种方法在一份记录中捕捉乳房的病史,这对于挛缩可能比植入物的差异更重要。通过讨论的修改,该研究可以扩大规模,涵盖实现强大统计效力所需的尽可能多的记录。这些数据将补充现有关于与包膜挛缩相关因素的文献,并确定影响包膜挛缩干预成功结局的因素。